Capital Analysts LLC Portfolio holdings
Capital Analysts is a Lincoln Investment company that provides a ready-made wealth management platform to independent financial professionals who serve affluent clients. Capital Analysts dates from 2012 and belongs to Lincoln Investment Capital Holdings; Lincoln Investment Planning, a brokerage and advisory firm under the same ownership, handles brokerage services for it and its advisors. Those advisors work across the United States as independent contractors, not employees. Their clients include individuals, high net worth individuals, trusts, foundations, businesses and charities, and Capital Analysts also offers its institutional advisory services to other advisers and trust companies. The portfolios it builds aim to be diversified and rest on asset allocation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$24.6M |
| 2 |
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
|
+$16.4M |
| 3 |
Fidelity Total Bond ETF
FBND
|
+$16.1M |
| 4 |
iShares Systematic Alternatives Active ETF
IALT
|
+$16M |
| 5 |
iShares Core Universal USD Bond ETF
IUSB
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$7.72M |
| 2 |
Citigroup
C
|
+$7.28M |
| 3 |
iShares Gold Trust
IAU
|
+$6.25M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.23M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$6.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.75% |
| 2 | Technology | 5.6% |
| 3 | Financials | 4.52% |
| 4 | Industrials | 2.67% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1401
Invesco Biotechnology & Genome ETF
PBE
$436M
| $5K | ﹤0.01% |
51
-1,087
| -96% | -$89.5K |
2024 Q1
9 quarters
|
|
1402
Franklin Municipal Opportunities Trust
PMO
$287M
| $5K | ﹤0.01% |
+447
| New | +$4.67K |
2026 Q2
0 quarters
|
|
1403
Rockwell Automation
ROK
$43.6B
| $5K | ﹤0.01% |
10
-3
| -23% | -$1.3K |
2023 Q2
12 quarters
|
|
1404
Roku
ROKU
$23.9B
| $5K | ﹤0.01% |
33
| – | – |
2025 Q1
5 quarters
|
|
1405
Ryanair
RYAAY
$31.7B
| $5K | ﹤0.01% |
77
| – | – |
2024 Q3
7 quarters
|
|
1406
Smith & Wesson
SWBI
$665M
| $5K | ﹤0.01% |
324
+3
| +0.9% | +$45 |
2025 Q3
3 quarters
|
|
1407
Viasat
VSAT
$10.1B
| $5K | ﹤0.01% |
59
-279
| -83% | -$18.5K |
2025 Q3
3 quarters
|
|
1408
WESCO International
WCC
$15.6B
| $5K | ﹤0.01% |
14
| – | – |
2020 Q3
23 quarters
|
|
1409
NEOS Gold High Income ETF
IAUI
$554M
| $5K | ﹤0.01% |
98
| – | – |
2026 Q1
1 quarter
|
|
1410
Archer Aviation
ACHR
$3.63B
| $4K | ﹤0.01% |
928
+188
| +25% | +$1.09K |
2021 Q3
19 quarters
|
|
1411
Amcor
AMCR
$21.1B
| $4K | ﹤0.01% |
95
| – | – |
2025 Q1
5 quarters
|
|
1412
ChargePoint
CHPT
$321M
| $4K | ﹤0.01% |
585
| – | – |
2022 Q2
16 quarters
|
|
1413
Cleveland-Cliffs
CLF
$7.06B
| $4K | ﹤0.01% |
400
| – | – |
2022 Q1
17 quarters
|
|
1414
Chipotle Mexican Grill
CMG
$45.2B
| $4K | ﹤0.01% |
127
+27
| +27% | +$882 |
2024 Q1
9 quarters
|
|
1415
Donaldson
DCI
$10.2B
| $4K | ﹤0.01% |
39
| – | – |
2023 Q4
10 quarters
|
|
1416
Embecta
EMBC
$358M
| $4K | ﹤0.01% |
1,219
-26
| -2% | -$142 |
2022 Q2
16 quarters
|
|
1417
Fomento Económico Mexicano
FMX
$44.5B
| $4K | ﹤0.01% |
31
| – | – |
2024 Q3
7 quarters
|
|
1418
First Trust Exchange-Traded Fund VI First Trust Hedged BuyWrite Income ETF
FTQI
$988M
| $4K | ﹤0.01% |
190
| – | – |
2024 Q2
8 quarters
|
|
1419
Chiron Real Estate Inc
XRN
$374M
| $4K | ﹤0.01% |
118
-59
| -33% | -$2.09K |
2025 Q3
3 quarters
|
|
1420
Grocery Outlet
GO
$1.35B
| $4K | ﹤0.01% |
400
| – | – |
2025 Q4
2 quarters
|
|
1421
KB Financial Group
KB
$39.5B
| $4K | ﹤0.01% |
41
-47
| -53% | -$4.97K |
2024 Q3
7 quarters
|
|
1422
Invesco KBW Bank ETF
KBWB
$6.78B
| $4K | ﹤0.01% |
39
| – | – |
2023 Q3
11 quarters
|
|
1423
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.51B
| $4K | ﹤0.01% |
+334
| New | +$4.21K |
2026 Q2
0 quarters
|
|
1424
Philips
PHG
$29.9B
| $4K | ﹤0.01% |
132
+29
| +28% | +$768 |
2014 Q1
49 quarters
|
|
1425
PPL Corp
PPL
$27.1B
| $4K | ﹤0.01% |
100
-16
| -14% | -$591 |
2025 Q1
5 quarters
|
|
Similar funds
Capital Analysts LLC's Q2 2026 Portfolio in Review
As of Q2 2026, Capital Analysts LLC held 1,612 positions worth $4.34B, up 14% from $3.81B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Analysts LLC deployed $223M of net new capital in Q2 2026, opening 75 new positions and adding to 544 existing holdings. Its largest new stake was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 75% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $7.72M trimmed.
- Capital Analysts LLC's largest Q2 2026 buy was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
- Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $24.6M increase.
- Capital Analysts LLC's biggest Q2 2026 reduction was Zoetis, cutting an estimated $7.72M.
- Capital Analysts LLC fully exited Hershey in Q2 2026, selling an estimated $113K.
- Capital Analysts LLC's ten largest holdings make up 30% of its $4.34B portfolio in Q2 2026.
- Capital Analysts LLC opened 75 new positions and closed 76 in Q2 2026.
- Capital Analysts LLC's portfolio value rose 14% quarter-over-quarter to $4.34B.
Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.